# UNIVERSITY OF CALIFORNIA LOS ANGELES: Leveraging JAK Inhibitors to Halt Autoimmune Attack Induced by Immune Checkpoint Inhibitors

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF CALIFORNIA LOS ANGELES |
| Location | LOS ANGELES, CA |
| Project | Leveraging JAK Inhibitors to Halt Autoimmune Attack Induced by Immune Checkpoint Inhibitors |
| Project number | 1U01AI201291-01 |
| Mechanism | U01 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $1,183,663 |
| Awarded | 2026-08-31 |
| Project period | 2026-09-01 to 2031-07-31 |
| UEI | RN64EPNH8JC6 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11426254). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.
